Rising Sales & Declining Cash Flows: The Aflac Investor Dilemma

Aflac reported strong first-half sales growth, with Japan up 18.7% and the U.S. up 3.1%, supported by a 22.5% U.S. pretax margin in Q2 due to cost discipline. Despite this top-line performance, the company faces a critical challenge as operating cash flow has declined for four consecutive years, including a 10.5% drop in the first half of 2025, alongside a multi-year decline in net earned premiums. This creates an investor dilemma, potentially constraining future growth investments, even as Aflac continues its robust capital deployment through share repurchases and a long dividend growth streak.

Analysis

Aflac exhibits a significant operational dichotomy, presenting a complex picture for investors. On one hand, the company demonstrates strong top-line momentum, with first-half sales growth of 18.7% in Japan and 3.1% in the U.S., supported by effective cost discipline that produced a 22.5% U.S. pretax margin in the second quarter. Management's guidance for 2025 remains robust, projecting pretax margins of 30-33% in Japan and 17-20% in the U.S. This is complemented by an aggressive capital return policy, evidenced by $2.4 billion in capital deployment in the first half of 2025 and a 42-year streak of dividend growth. However, these strengths are critically undermined by a severe and persistent decline in core financial health metrics. Operating cash flow has fallen for four consecutive years and dropped another 10.5% in the first half of 2025. This, coupled with a four-year decline in net earned premiums, signals significant business headwinds and questions the long-term sustainability of its shareholder reward programs and the capacity for future growth investments.

Key Decisions for Investors

• Investors should scrutinize upcoming earnings reports for any reversal in the multi-year decline of operating cash flow, as this is the primary risk factor overshadowing positive sales and margin performance.
• Evaluate the sustainability of Aflac's aggressive share repurchase program and dividend growth in the context of weakening cash generation, as this capital deployment may become unsupportable if operational trends do not improve.
• Consider the current valuation to determine if the market has adequately priced in the fundamental risk posed by declining cash flows and net earned premiums, not just the headline sales growth and shareholder returns.